Profile
| Metric | Value |
|---|---|
| Full Name | Danaher Corporation |
| Ticker | NYSE: DHR |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | |
| Website | danaher.com |
| Employees | 61,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $235.56 | |
| Price, 1D Change | -1.44% | |
| Market Cap | $166B | |
| TTM Dividend Yield | 0.54% | |
| PE Ratio | 48.48 | |
| Beta | 0.93 | |
| Revenue | $24B | |
| Revenue, 1Y Change | -0.06% | |
| EPS | $5.29 | |
| EPS, 1Y Change | -17.14% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.32 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 141:125 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $5.29 | |
| EPS Estimate | $7.71 | |
| EPS Est. Change | +45.85% | |
| Revenue | $23.88B | |
| Revenue Estimate | $24.51B | |
| Revenue Est. Change | +2.66% | |
| Current Price | $235.56 | |
| Price Target | - | $262.50 |
| Price Tgt. Change | - | +11.44% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $7.53 | $6.38 | -15.24% | |
| $7.51 | $5.29 | -29.55% | |
| $7.71 | N/A | +45.85% | |
| $8.42 | N/A | +59.24% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $24.86B | $23.89B | -3.89% | |
| $23.83B | $23.88B | +0.19% | |
| $24.51B | N/A | +2.66% | |
| $25.50B | N/A | +6.82% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -1.80% | |
| Price, 3Y | -2.89% | |
| Market Cap, 1Y | -3.54% | |
| Market Cap, 3Y | -5.82% | |
| Revenue, 1Y | -0.06% | |
| Revenue, 3Y | -18.94% | |
| EPS, 1Y | -17.14% | |
| EPS, 3Y | -38.60% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $235.56 | |
| SMA 200 | $205.62 | |
| SMA 200 vs Price | -12.71% | |
| SMA 50 | $225.74 | |
| SMA 50 vs Price | -4.17% | |
| Beta | 0.93 | |
| ATR | $5.00 | |
| 14-Day RSI | 59.29 | |
| 10-Day Volatility | 16.53% | |
| 1-Year Volatility | 32.74% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.32 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 0.46% | |
| Total Dividend | $1.08 | |
| Dividends Paid | $768.00M | |
| Payout Ratio | 19.70% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $23.88B | |
| EPS | $5.29 | |
| Gross Profit | $14.21B | |
| Gross Margin | 59.50% | |
| Operating Profit | $5.18B | |
| Operating Margin | -18.79% | |
| Net Income | $3.90B | |
| Net Margin | 16.33% | |
| EBITDA | $7.54B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.35 | |
| Current Ratio | 1.40 | |
| Quick Ratio | 1.05 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 4.93 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 48.48 | |
| PS Ratio | 6.86 | |
| PB Ratio | 3.26 | |
| EV/EBITDA | 23.16 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $49.54B | |
| Cash & Equivalents | $2.08B | |
| Total Assets | $77.54B | |
| Current Assets | $9.50B | |
| Total Liabilities | $27.99B | |
| Current Liabilities | $6.80B | |
| Total Debt | $17.15B | |
| Short Term Debt | $678.00M | |
| Accounts Payable | $1.75B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $19.98B | |
| Operating Expenses | $9.02B | |
| Cost Of Goods Sold | $9.67B | |
| SG&A | $0.00 | |
| D&A | $2.35B | |
| Interest Expense | $0.00 | |
| Income Tax | $747.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $6.69B | |
| CFI | -$1.98B | |
| CFF | -$8.39B | |
| Capex | $1.39B | |
| Free Cash Flow | $5.30B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| TD Cowen | → | |
| Guggenheim | → | |
| Wells Fargo | → | |
| Goldman Sachs | ||
| Morgan Stanley | ||
| Wells Fargo | → | |
| TD Cowen | → | |
| Barclays | → | |
| Rothschild & Co | → | |
| Evercore ISI Group | → |
Analyst sentiment
Institutional ownership
Screeners with DHR
Data Sources & References
- DHR Official Website www.danaher.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/313616/000031361625000182/0000313616-25-000182-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/313616/000031361625000043/0000313616-25-000043-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- DHR Profile on Yahoo Finance finance.yahoo.com/quote/DHR
- DHR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dhr
FAQ
What is the ticker symbol for Danaher Corporation?
The ticker symbol for Danaher Corporation is NYSE:DHR
Does Danaher Corporation pay dividends?
Yes, Danaher Corporation pays dividends. The last payment was $0.32, with an ex-dividend date on December 26, 2025
What sector is Danaher Corporation in?
Danaher Corporation is in the Healthcare sector
What industry is Danaher Corporation in?
Danaher Corporation is in the Diagnostics & Research industry
What country is Danaher Corporation based in?
Danaher Corporation is headquartered in United States
When did Danaher Corporation go public?
Danaher Corporation initial public offering (IPO) was on December 29, 1978
Is Danaher Corporation in the S&P 500?
Yes, Danaher Corporation is included in the S&P 500 index
Is Danaher Corporation in the NASDAQ 100?
No, Danaher Corporation is not included in the NASDAQ 100 index
Is Danaher Corporation in the Dow Jones?
No, Danaher Corporation is not included in the Dow Jones index
When was Danaher Corporation last earnings report?
Danaher Corporation's most recent earnings report was on October 21, 2025
When does Danaher Corporation report earnings?
The next expected earnings date for Danaher Corporation is January 28, 2026